- Open Access
Heterogeneous virulence of pandemic 2009 influenza H1N1 virus in mice
© Farooqui et al.; licensee BioMed Central Ltd. 2012
- Received: 3 September 2011
- Accepted: 10 May 2012
- Published: 6 June 2012
Understanding the pathogenesis of influenza infection is a key factor leading to the prevention and control of future outbreaks. Pandemic 2009 Influenza H1N1 infection, although frequently mild, led to a severe and fatal form of disease in certain cases that make its virulence nature debatable. Much effort has been made toward explaining the determinants of disease severity; however, no absolute reason has been established.
This study presents the heterogeneous virulence of clinically similar strains of pandemic 2009 influenza virus in human alveolar adenocarcinoma cells and mice. The viruses were obtained from patients who were admitted in a local hospital in China with a similar course of infection and recovered. The A/Nanchang/8002/2009 and A/Nanchang/8011/2009 viruses showed efficient replication and high lethality in mice while infection with A/Nanchang/8008/2009 was not lethal with impaired viral replication, minimal pathology and modest proinflammatory activity in lungs. Sequence analysis displayed prominent differences between polymerase subunits (PB2 and PA) of viral genomes that might correlate with their different phenotypic behavior.
The study confirms that biological heterogeneity, linked with the extent of viral replication, exists among pandemic H1N1 strains that may serve as a benchmark for future investigations on influenza pathogenesis.
- Pandemic H1N1 influenza
- Viral heterogeneity
- Clinical presentation
- Host adaptation
- Viral polymerase
Genetic, demographic and Clinical background of 2009 pdm H1N1 influenza strains
Day of sample collection
9 Dec 2009
19 Dec 2009
22 Dec 2009
Lethality in mice
Viral loads in mice lungs
Replication in A549 cells
1 x 104.83
1 x 104.33
1 x 106.4
1 x 107.75
1 x 106.4
Several laboratory animals including mice, ferrets, cotton rats and nonhuman primates have been successfully used as suitable models of influenza infection . Among them ferrets are considered the best because of their natural susceptibility to the virus and its similar pathogenesis to that of humans ; however, their use in large-scale screening is not feasible. Small laboratory animals, particularly mice, have shown promising potential for virological studies. We have previously described the infection of prototypic pdm H1N1 strain, A/ Mexico/4108/2009 in mice with significant viral replication and marked lung pathology .
The high magnitude of the 2009 pandemic and potential risk of future outbreaks necessitate the evaluation of newer viral strains to resolve ambiguities about the severity of infection. In this study, we evaluated three different H1N1 influenza viruses that were isolated from adult patients admitted in a local hospital in the southern part of China during the second pandemic wave. Interestingly, these strains exhibited mild to severe pathogenic potential in terms of viral replication, disease progression, and induction of proinflammatory response in vitro and in vivo. Sequence analysis reveals that the mutations in polymerase subunits (PB2 and PA) might correlate with the phenotypic trait of the viruses. This study presents the co-circulation of heterogeneous pdm H1N1 during this period that cannot be a neglected factor in evaluating the pathogenesis of 2009 pandemic influenza infection.
Differential response of pdm H1N1 strains in A549 cells
The above-mentioned results indicated relatively poor replication ability of the NC8 strain in mammalian cells coupled with weak inflammatory response that prompted us to scrutinize how NC8 behaves in an avian environment. In contrast with A549 cells, a different situation was observed in chicken embryo nated eggs in which the virus titers of NC8 were higher than those from NC2 and NC11 (Table 1).
Differential pathogenesis of pdmH1N1 strains in mice
Altered replication of viral strains in mice
Evaluation of host immune responses
On the basis of the above-mentioned data, we chose the NC2 infection model to compare the kinetic response in BALB/C and C57/BL6 mice by real time RT-PCR analysis. More robust gene expression was observed in C57/BL6 mice compared with BALB/C, who showed comparatively attenuated responses throughout the experiment. In C57/BL6 mice, proinflammatory response was marked with significant induction of early immune mediators such as CXCL10, IFN β and TNFα. The trend was similar for IL6, indicating the classical switching of innate and adaptive arms. The highest level of expression was achieved at 1 d.p.i. in each case with the exception of IL28A, which was progressively increased over time (additional file 2).
Whole viral genomes of these strains were further sequenced to evaluate genetic mutations that might explain their biological behavior in cells and mice. Sequences were deposited to Genbank [Genbank: JF800142, JF800143, CY089607, CY089608, CY089609, CY089610, CY089611, CY089612] for A/Nanchang/8002/2009 (NC2), [Genbank: CY089613, CY089614, CY089615, CY089616, CY089617, CY089618, CY089619, CY089620] for A/Nanchang/8008/2009 (NC8) and [Genbank: CY089621, CY089622, CY089623, CY089624, CY089625, CY089626, CY089627, CY089628] for A/ Nanchang/8011/2009 (NC11) strain.
Several mutations were found in each gene segment with respect to prototypic pdm H1N1 strains, A/California/07/2009 and A/California/04/2009. Comparison between NC2, NC8 and NC11 genomes revealed that NC8 differed from NC2 and NC11 at three different positions in polymerase subunits PB2-V227I, R299K and PA-E243G. HA analysis also showed the substitution of alanine at position 409 in NC2 and NC11 which was not present in NC8 (Table 1). Experimental data have already shown that NC2 and NC11 are more virulent than NC8 due to efficient viral replication; possibly these amino acid residues in PB2, PA and HA gene have an important role in host adaptation and the virulence of pdm H1N1 influenza virus. However, additional studies are required to probe the biological relevance of these amino acid changes.
Genetic characterization of NA, PB1, NP, NS1 and M2 also showed various mutations in these segments; however, none of them clearly defined the different pathogeneses of these pdm H1N1 strains (additional file 3).
Here we present the heterogeneous virulence of three different strains of influenza H1N1 in human adenocarcinoma cells (A549) and mice that were isolated from clinically similar human cases from South China in December 2009. Two different patterns of biological heterogeneity were observed: first, two strains (NC2 and NC11) showed efficient viral replication and subsequent effects on tissue histology, induction of proinflammatory response and causing lethality in mice, although their behavior was not totally identical and some minor differences in the kinetics of the disease in mice were observed. Secondly, NC8 showed delayed replication that eventually led to non-lethal infection and muted inflammatory response in mice. These results have a relevance to the previously published epidemiological reports that associate effective viral replication and delayed clearance with disease severity in humans [9, 15, 16]. Most of the previous studies agree that pdm H1N1 exert homogeneous and modest infection but with efficient pulmonary viral replication in mice ; however, its pathogenesis is more than that of seasonal strains [5, 18] and subdued compared with 1918 pandemic and other swine origin influenza viruses [17, 19]. Nonetheless, the virus has been shown to increase virulence upon expression of truncated viral proteins by reverse genetic tools and after mice adaptation . In addition to the heterogeneous nature of these strains, we also demonstrate that C57/BL6 mice are more susceptible for pdm H1N1 infection than BALB/C strains; however, variation in disease kinetics did not change the infectivity ratios as observed previously .
In this study, NC2 and NC11 viruses were able to induce of proinflammatory cytokines effectively whereas immune responses were mute in the case of NC8 infection. It is interesting to note that pdm H1N1 strains also display a differential cytokine response which may or may not be linked with viral growth. Previous studies have shown a robust gene expression of innate immune response genes with delayed switch to adaptive immunity after pdm H1N1 infection; however, overall responses are considered to be higher compared with those of contemporary seasonal strains [7, 17].
Clinically, 2009 influenza pandemic caused self recovering mild disease in the vast majority of patients while only a small group of patients developed serious respiratory complications [21, 22]. No explanation has yet been offered for why the clinical profile varies from one patient to another. The published studies interrogating host markers and viral pathogenesis in vitro and in vivo are mostly limited to the characterization of a narrow range of prototypic pdm H1N1 strains [5, 17–19]. Consequently, important aspects of the disease may remain unexplored. Pandemics provide a greater chance for influenza viruses to mutate; however, unveiling their impact on viral pathogenecity is an enduring goal that can be achieved by continuous surveillance. Lab investigation of newer strains might provide valuable information about the pathogenesis that could be missing in initial studies.
In the present study, although all these viral strains were isolated from patients who finally recovered, the viruses were able to produce biological heterogeneity in mice that refute the common paradigm of the evaluation of influenza pathogenesis which is at present based on the clinical profile and disease outcome of patients. Such attributes have previously been observed in clinically relevant influenza H5N1 strains [23, 24]. In humans, viral heterogeneity may have specific effects on individuals with different genetic background and demography; therefore, infection with such viruses might result in a variable clinical course of infection. However, it is also important to remember that treatment strategies, immunocompetance, and clinical management influence the disease severity and outcome and consequently mask the true picture of viral pathogenesis.
Virulence and interspecies transmission of influenza virus is often considered a polygenic phenomena [25–28]. The triple reassortant pandemic 2009 influenza virus stands out from ancestral pandemic and reassorted strains because it rapidly transmits to humans despite the absence of any traditional virulence markers; for example, the C-terminal PDZ ligand domain of NS1 , functional PB1-F2 protein, and PB2- K627 . Therefore, efforts have been made to determine other possible virulence determinant(s). Recent laboratory investigations conducted with mouse adapted pdm H1N1 strains speculate the role of HA (D131E and S186P)  and PB2 genes, such as glutamate-to-glycine substitution at 158 , aspartate to asparagines at 701 , Threonine-to-alanine at 271  and second site suppressor mutation  in viral replication and mouse adaptation, although none of them was demonstrated in wild type strains. In this study, the genetic characterization showed that the non-lethal NC8 strain contained three mutations (PB2-V227I, R299K and PA-E243G) in polymerase subunits compared with virulent strains. Previous studies have reported that both PB2 and PA genes are genetically linked with each other ; furthermore, N-terminal mutations in these genes might lead to intermediate or complete loss of viral RNA transcription . Therefore, we might speculate that these mutations are interlinked and collectively responsible for altered replication of the NC8 strain. On the other hand, this virus (NC8) strikingly replicated more than other viruses with > log10 ratio in embryonated chicken eggs, indicating the ease of growth in an avian environment. Here it is important to consider that the 2009 pandemic virus contains polymerase subunits PB2 and PA of North American avian lineage. We do not know whether these substitutions in NC8 are the remains of ancestral avian strains or not, but upon sequence analysis of global pdm H1N1 isolates, we found that these amino acid residues (PB2-I227, K299, PA-G243) are conserved in pdm H1N1 strains, thus raising the possibility that collectively they have some role in the adaptation to the mammalian host and they might link to the heterogeneity of pdm H1N1. However, in vivo studies with mutant strains are required to prove the hypothesis. In the case of HA gene, NC2 and NC11 contained the A409V mutation compared to NC8 and prototype California strains. It is worthwhile to indicate that NC2 also exhibited HA-E391K, which has recently been identified as a fast-growing mutation with the ability to destabilize the HA oligomerization process, thus modifying the membrane fusion properties of the pandemic influenza virus [36, 37]. However, no association with virulence and progression of disease has been established yet. Taken together, we hypothesize that these mutations in PB2, PA and HA genes might have no relevance with human disease but in the case of zoonotic transmission of influenza viruses to human, it may yield more pathogenic viruses.
In conclusion, the study provides evidence about the heterogeneous replication and virulence of clinically relevant pandemic influenza H1N1 viruses in mice and human alveolar adenocarcinoma cells. Replication efficiencies might link with the notable mutations in viral polymerase complex genes PB2 and PA. Heterogeneous virulence that the viruses displayed in cells and mice may not be linked with the human disease; however, it provides a background to understand the differences in symptomatology, immune responses, and viral dynamics of clinically relevant cases. The study mandates the more comprehensive analysis of 2009 pandemic influenza H1N1 strains and the factors which might be responsible for a different phenotypic behavior in humans.
A total of three pandemic Influenza H1N1 strains, namely A/Nanchang/8002/2009 (NC2), A/Nanchang/8008/2009 (NC8), A/Nanchang/8011/2009 (NC11), were used for in vitro and in vivo studies. All were isolated from nasopharyngeal (NP) swabs of adult patients who were admitted to a local hospital in Nanchang, Jiangxi province of China, in December 2009. Samples were collected before initiation of virological treatment in each case. These patients had similar courses of infection in terms of viral shedding and disease severity. They had no underlying illnesses (Table 1). All patients eventually recovered. Viral isolation was attained in 9- to 11-day-old embryonated eggs as described previously  with the exception of incubation at 33 °C. Samples with hemagglutination titer > 1:2 were considered positive and further confirmed by real time RT-PCR for pdm H1N1 virus using pandemic H1N1 influenza diagnostic kit (Liferiver, Shanghai, China) based on World Health Organization and US CDC protocol . The viral stocks were further titrated by egg infectious dose50 (EID50) and used for in vitro and in vivo assays without further passage.
Whole viral genome sequencing was performed for each strain. RNA were extracted from NP swabs using Trizol (invitrogen) followed by reverse transcription by high-capacity cDNA RT kit (Applied Biosystems, Foster City, USA) and PCR using primers specific for each viral gene segment. Purified PCR preps (Promega, Madison, USA) were sequenced from Invitrogen (Guangzhou, China). Sequences were aligned and assessed by ClustalW multiple alignment tools. Comparisons were made with the prototype strains A/California/04/2009 and A/California/07/2009.
Infection in human adenocarcinoma alveaolar epithelial (A549) cells
An in vitro infection model was developed in adenocarcinoma human alveolar epithelial cells (A549) (ATCC, USA). Briefly, A549 cells, freshly seeded in 24-well plates, were infected with three different strains of pdm H1N1 (NC2, NC8, NC11) at MOI 2 in vHAM’s F12 medium (M & C Gene Technology) containing 1 μg/ml of TPCK trypsin. MOI was calculated by EID50 titers. After 2 hrs of adsorption, cell supernatants were replaced with fresh medium followed by incubation at 37 °C. Similar treatment with the exception of virus was provided to uninfected cells (blank). Each point was performed in six replicate wells and the experiment was repeated thrice.
For kinetic studies, samples were collected at different time points such as 8 h post infection, 1 day post infection (d.p.i.) and 2 d.p.i.. In the case of the viral loads, supernatants were collected and titrated in MDCK cells (ATCC). For the determination of immune mediators, RNA was extracted using the SV total RNA isolation system (Promega) and reverse transcribed with the high-capacity cDNA RT kit (Applied Biosystems, Foster City, USA) followed by amplification using SYBR Green master mix (Invitrogen). Relative gene expression was calculated after normalization with human β-actin gene.
Confocal laser fluorescent microscopy
A549 Cells seeded on 24-well plates containing cover glass were infected with viral strains at MOI 2 for 1 h at 37 °C followed by washing with HEPES (sigma) thrice and the addition of vHAMF12 medium (with no TPCK-trypsin). Cells were incubated at 37 °C for different time intervals, fixed with 2% paraformaldehyde and blocked with 5% bovine serum albumin (BSA) (Sigma). Viral staining was performed with influenza A nucleoprotein antibody (southern biotech) for 16 h at 4 °C. Alexa fluor 555 goat anti mouse IgG (H + L) (Beyotime) diluted 1: 500 in PBS containing 0.05% Tween20 and 3% BSA was used as a secondary antibody while cells were stained for DNA using 4′,6, diamino-2-phenylindole (DAPI) (Sigma) diluted 1:1000 in PBS. Slides were observed by confocal laser fluorescence microscope (Olympus Fluoview FV1000). Data is the representative of three independent experiments.
Female C57/BL6 and BALB/C mice (8–10 weeks of age) were obtained from Vital River Laboratory (Beijing, China) and maintained on a standard animal diet in a SPF facility with controlled temperature and humidity. Initially, to compare the virulence and pathogenesis of viral strains (NC2, NC8, NC11), C57/BL6 mice (n = 10) were intranasally infected with 105 EID50 in a final volume of 50 μl. NC8 infection at a higher dose of 106 EID50 was further compared with NC2 and NC11 due to non-lethal infection. To investigate the detailed virulence profile of pdm H1N1 strains, MLD50 experiments were set up in C57/BL6 and BALB/C mice. Animals were grouped (n = 10) and infected with 10-fold diluted pdm H1N1 influenza strains ranging from 106 to 103 per mouse. Mock infection with HBSS was given to healthy controls. Animals were observed daily for weight loss and mortality up to 14 d.p.i.. A loss of more than 20% in original body weight was considered the humane end point for mortality.
Three animals from each group were euthanized at days 0, 1 and 3 p.i. and their organs collected, i.e., lungs, liver and brain. Organ homogenates were prepared in vDMEM (10% w/v) and assayed for viral loads in MDCK cells with the detection limit of 10 TCID50/ml as described previously .
On days 0, 1 and 3, p.i. animals were euthanized, and lung tissues were removed and fixed in 10% buffered formalin. Fixed tissues were processed for paraffin wax-embedded sectioning and 5 μm thin sections were stained with hematoxylin and eosin (H & E) and observed; pictures were taken using a Nikon Eclipse 80i microscope (Nikon).
Measurement of cytokines by quantitative PCR (qPCR)
For the measurement of host immune response, lungs of virus-infected animals (n = 5/group) were collected in an RNAlater (Ambion Inc) at different time intervals. Expression of immune response genes was studied by real time qPCR performed with 0.5pmol/μl of forward and reverse primers targeting the gene of interest. Reactions were run in duplicate, and mean values were normalized with β-actin gene expression. Primer pairs and PCR conditions will be provided upon request.
Statistical analyses were performed using PAWS Statistics 18 (SPSS Inc., Chicago, IL, USA). Fisher’s exact and Chi square tests were used for comparison of categorical data, and the two-tailed t-test was applied in cases of continuous variables. Survival analyses were performed by the Kaplan-Meier method and significant differences were measured by log-rank test. Contingency analysis was applied to assess the number of survivors in each group. Significant differences in viral loads, cytokine measurement, and weight loss and hazard ratios were analyzed by Student’s t-test.
This study was approved by the ethical committees of Shantou University Medical College, Shantou, China (permit number SUMC 2011–058) and Infectious Disease Hospital, Nanchang University, Nanchang 9th Hospital (permit number 2009–02). Written consents were obtained from all participants involved in the study.
We thank the Li Ka-Shing Foundation of Canada, Immune Diagnostics & Research, and Shantou University Medical College for support to conduct this study. Confocal laser fluorescence microscopy was performed in the Center of Neuroscience, Shantou University Medical College. We also extend our gratitude to Nikki Kelvin for the technical revision of the manuscript.
- Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al: Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science. 2009, 325: 197-201. 10.1126/science.1176225.PubMedPubMed CentralView ArticleGoogle Scholar
- Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, et al: Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA. 2009, 302: 1896-1902. 10.1001/jama.2009.1583.PubMedView ArticleGoogle Scholar
- Shiley KT, Nadolski G, Mickus T, Fishman NO, Lautenbach E: Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. Infect Cntrl Hosp Epidemiol. 2010, 31: 676-682. 10.1086/653204.View ArticleGoogle Scholar
- Chudasama RK, Patel UV, Verma PB: Hospitalizations associated with 2009 influenza A (H1N1) and seasonal influenza in Saurashtra region, India. J Infect Dev Ctries. 2010, 4: 834-841.PubMedView ArticleGoogle Scholar
- Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H, Gustin KM, Pearce MB, Viswanathan K, Shriver ZH, et al: Transmission and pathogenesis of swine-origin 2009 A (H1N1) influenza viruses in ferrets and mice. Science. 2009, 325: 484-487.PubMedPubMed CentralGoogle Scholar
- Munster VJ, de Wit E, van den Brand J, Herfst S, Schrauwen EJA, Bestebroer TM, van de Vijver D, Boucher CA, Koopmans M, Rimmelzwaan GF: Pathogenesis and transmission of swine-origin 2009 A (H1N1) influenza virus in ferrets. Science. 2009, 325: 481-PubMedGoogle Scholar
- Rowe T, León AJ, Crevar CJ, Carter DM, Xu L, Ran L, Fang Y, Cameron CM, Cameron MJ, Banner D, et al: Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology. 2010, 401: 257-265. 10.1016/j.virol.2010.02.020.PubMedPubMed CentralView ArticleGoogle Scholar
- Shieh WJ, Blau DM, Denison AM, DeLeon-Carnes M, Adem P, Bhatnagar J, Sumner J, Liu L, Patel M, Batten B: 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol. 2010, 177: 166-175. 10.2353/ajpath.2010.100115.PubMedPubMed CentralView ArticleGoogle Scholar
- To KKW, Hung IFN, Li IWS, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt CL, et al: Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010, 50: 850-859. 10.1086/650581.PubMedView ArticleGoogle Scholar
- Sharma V, Verma PK, Gupta S, Sharma A: Mortality from Influenza A/H1N1 in a tertiary care teaching institution in North India. J Infect Dev Ctries. 2010, 4: 468-471.PubMedView ArticleGoogle Scholar
- Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, Gardner D, Proll SC, Marzi A, Tsuda Y, et al: Pandemic Swine-Origin H1N1 Influenza A Virus Isolates Show Heterogeneous Virulence in Macaques. J Virol. 2011, 85: 1214-1223. 10.1128/JVI.01848-10.PubMedPubMed CentralView ArticleGoogle Scholar
- Barnard DL: Animal models for the study of influenza pathogenesis and therapy. Antiviral Res. 2009, 82: A110-A122. 10.1016/j.antiviral.2008.12.014.PubMedPubMed CentralView ArticleGoogle Scholar
- Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, Turner PV, Ran R, Danesh A, Fang Y, Chan PKM: Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. J Virol. 2008, 82: 11308-11317. 10.1128/JVI.00691-08.PubMedPubMed CentralView ArticleGoogle Scholar
- Rowe T, Banner D, Farooqui A, Ng DCK, Kelvin AA, Rubino S, Huang SSH, Fang Y, Kelvin DJ: In vivo ribavirin activity against severe pandemic H1N1 influenza A/Mexico/4108/2009. J Gen Virol. 2010, 91: 2898-2906. 10.1099/vir.0.024323-0.PubMedView ArticleGoogle Scholar
- Li CC, Wang L, Eng HL, You HL, Chang LS, Tang KS, Lin YJ, Kuo HC, Lee IK, Liu JW, et al: Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis. 2010, 16: 1265-1272. 10.3201/eid1608.091918.PubMedPubMed CentralView ArticleGoogle Scholar
- Arankalle VA, Lole KS, Arya RP, Tripathy AS, Ramdasi AY, Chadha MS, Sangle SA, Kadam DB: Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One. 2010, 5: e13099-10.1371/journal.pone.0013099.PubMedPubMed CentralView ArticleGoogle Scholar
- Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, Pearce MB, Zeng H, Swayne DE, Pantin-Jackwood M, Katz JM, Tumpey TM: Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J Virol. 2010, 84: 4194-4203. 10.1128/JVI.02742-09.PubMedPubMed CentralView ArticleGoogle Scholar
- Zeng H, Pappas C, Katz JM, Tumpey TM: The 2009 Pandemic H1N1 and Triple-Reassortant Swine H1N1 Influenza Viruses Replicate Efficiently but Elicit an Attenuated Inflammatory Response in Polarized Human Bronchial Epithelial Cells. J Virol. 2011, 85: 686-696. 10.1128/JVI.01568-10.PubMedPubMed CentralView ArticleGoogle Scholar
- Osterlund P, Pirhonen J, Ikonen N, Ronkko E, Strengell M, Makela SM, Broman M, Hamming OJ, Hartmann R, Ziegler T, Julkunen I: Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol. 2010, 84: 1414-1422. 10.1128/JVI.01619-09.PubMedPubMed CentralView ArticleGoogle Scholar
- Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki H, Barman S, Webster RG, Webby RJ: Adaptation of pandemic H1N1 influenza viruses in mice. J Virol. 2010, 84: 8607-8616. 10.1128/JVI.00159-10.PubMedPubMed CentralView ArticleGoogle Scholar
- Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM, Team NS-OIAHNVI: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New Engl J Med. 2009, 360: 2605-2615.PubMedView ArticleGoogle Scholar
- Abdo A, Alfonso C, Diaz G, Wilford M, Rocha M, Verdecia N: Fatal 2009 pandemic influenza A (H1N1) in a bone marrow transplant recipient. J Infect Dev Ctries. 2010, 5: 132-137.Google Scholar
- Gao P, Watanabe S, Ito T, Goto H, Wells K, McGregor M, Cooley AJ, Kawaoka Y: Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol. 1999, 73: 3184-3189S.PubMedPubMed CentralGoogle Scholar
- Dybing JK, Schultz-Cherry S, Swayne DE, Suarez DL, Perdue ML: Distinct pathogenesis of Hong Kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol. 2000, 74: 1443-1450. 10.1128/JVI.74.3.1443-1450.2000.PubMedPubMed CentralView ArticleGoogle Scholar
- Li Z, Chen H, Jiao P, Deng G, Tian G, Li Y, Hoffmann E, Webster RG, Matsuoka Y, Yu K: Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol. 2005, 79: 12058-12064. 10.1128/JVI.79.18.12058-12064.2005.PubMedPubMed CentralView ArticleGoogle Scholar
- Jackson D, Hossain M, Hickman D, Perez DR, Lamb RA: A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci. 2008, 105: 4381-4386. 10.1073/pnas.0800482105.PubMedPubMed CentralView ArticleGoogle Scholar
- Shinya K, Watanabe S, Ito T, Kasai N, Kawaoka Y: Adaptation of an H7N7 equine influenza A virus in mice. J Gen Virol. 2007, 88: 547-558. 10.1099/vir.0.82411-0.PubMedView ArticleGoogle Scholar
- Gabriel G, Abram M, Keiner B, Wagner R, Klenk HD, Stech J: Differential polymerase activity in avian and mammalian cells determines host range of influenza virus. J Virol. 2007, 81: 9601-9604. 10.1128/JVI.00666-07.PubMedPubMed CentralView ArticleGoogle Scholar
- Ye J, Sorrell EM, Cai Y, Shao H, Xu K, Pena L, Hickman D, Song H, Angel M, Medina RA: Variations in the Hemagglutinin of the 2009 H1N1 Pandemic Virus: Potential for Strains with Altered Virulence Phenotype?. PLoS Pathog. 2010, 6: e1001145-10.1371/journal.ppat.1001145.PubMedPubMed CentralView ArticleGoogle Scholar
- Zhou B, Li Y, Halpin R, Hine E, Spiro DJ, Wentworth DE: PB2 Residue 158 Is a Pathogenic Determinant of Pandemic H1N1 and H5 Influenza A Viruses in Mice. J Virol. 2011, 85: 357-265. 10.1128/JVI.01694-10.PubMedPubMed CentralView ArticleGoogle Scholar
- Ping J, Dankar SK, Forbes NE, Keleta L, Zhou Y, Tyler S, Brown EG: PB2 and Hemagglutinin Mutations Are Major Determinants of Host Range and Virulence in Mouse-Adapted Influenza A Virus. J Virol. 2010, 84: 10606-10618. 10.1128/JVI.01187-10.PubMedPubMed CentralView ArticleGoogle Scholar
- Bussey KA, Bousse TL, Desmet EA, Kim B, Takimoto T: PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. J Virol. 2010, 84: 4395-4405. 10.1128/JVI.02642-09.PubMedPubMed CentralView ArticleGoogle Scholar
- Mehle A, Doudna JA: Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci. 2009, 106: 21312-21316. 10.1073/pnas.0911915106.PubMedPubMed CentralView ArticleGoogle Scholar
- Treanor J, Perkins M, Battaglia R, Murphy BR: Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus. J Virol. 1994, 68: 7684-7688.PubMedPubMed CentralGoogle Scholar
- Perales B, Sanz-Ezquerro JJ, Gastaminza P, Ortega J, Santaren JF, Ortin J, Nieto A: The replication activity of influenza virus polymerase is linked to the capacity of the PA subunit to induce proteolysis. J Virol. 2000, 74: 1307-1312. 10.1128/JVI.74.3.1307-1312.2000.PubMedPubMed CentralView ArticleGoogle Scholar
- Potdar VA, Chadha MS, Jadhav SM, Mullick J, Cherian SS, Mishra AC: Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS One. 2010, 5: e9693-10.1371/journal.pone.0009693.PubMedPubMed CentralView ArticleGoogle Scholar
- Barrero PR, Viegas M, Valinotto LE, Mistchenko AS: Genetic and phylogenetic analyses of Influenza A H1N1pdm in Buenos Aires, Argentina. J Virol. 2011, 85: 1058-1066. 10.1128/JVI.00936-10.PubMedPubMed CentralView ArticleGoogle Scholar
- Szretter KJ, Balish AL, Katz JM: Influenza: propagation, quantification, and storage. Current Protocols in Microbiology Volume 1, Chapter 15. 2006, John Wiley & Sons, Inc, New Jersey, Unit 15G.11Google Scholar
- CDC Protocol for realtime RTPCR for influenza A(H1N1) - revision 1. , , , http://www.who.int/csr/resources/publications/swineflu/CDCrealtimeRTPCRprotocol_20090428.pdf,
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.